ANTI-PD1 THERAPY BASED ON RESPONSE TO IFN-I STIMULATION Application WO-2023060361-A1 World Intellectual Property Organisation (WIPO) 20 Apr 2023
Immunopotentiating compositions comprising anti-PD-L1 antibodies Application EP-2206517-A1 European Patent Office 14 Jul 2010